These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31356559)
1. The Clinician's Guide to Proton-Pump Inhibitor Discontinuation. Wiens E; Kovaltchouk U; Koomson A; Targownik LE J Clin Gastroenterol; 2019 Sep; 53(8):553-559. PubMed ID: 31356559 [TBL] [Abstract][Full Text] [Related]
2. Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey. Kurlander JE; Kennedy JK; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Saini SD Am J Gastroenterol; 2019 Feb; 114(2):244-249. PubMed ID: 30694867 [TBL] [Abstract][Full Text] [Related]
3. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan. Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803 [TBL] [Abstract][Full Text] [Related]
4. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice? Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678 [TBL] [Abstract][Full Text] [Related]
5. We have had a gutful: The need for deprescribing proton pump inhibitors. Naunton M; Peterson GM; Deeks LS; Young H; Kosari S J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169 [TBL] [Abstract][Full Text] [Related]
6. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing. Dharmarajan TS J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078 [TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Targownik LE; Fisher DA; Saini SD Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361 [TBL] [Abstract][Full Text] [Related]
8. Risk awareness for proton pump inhibition: Necessitates review of recommendations in anti-reflux disease. Falk GL Surgeon; 2020 Jun; 18(3):189-190. PubMed ID: 31610985 [No Abstract] [Full Text] [Related]
9. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey. Kurlander JE; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Zikmund-Fisher BJ; Yang YX; Laine L; Weissman A; Saini SD Am J Gastroenterol; 2020 May; 115(5):689-696. PubMed ID: 32091419 [TBL] [Abstract][Full Text] [Related]
10. Successful deprescribing of unnecessary proton pump inhibitors in a primary care clinic. Odenthal DR; Philbrick AM; Harris IM J Am Pharm Assoc (2003); 2020; 60(1):100-104. PubMed ID: 31601478 [TBL] [Abstract][Full Text] [Related]
11. Problems Associated with Deprescribing of Proton Pump Inhibitors. Helgadottir H; Bjornsson ES Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070 [TBL] [Abstract][Full Text] [Related]
12. Deprescribing in a family health team: a study of chronic proton pump inhibitor use. Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559 [TBL] [Abstract][Full Text] [Related]
13. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System. Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549 [TBL] [Abstract][Full Text] [Related]
14. Deprescribing proton pump inhibitors. Turner JP; Thompson W; Reeve E; Bell JS Aust J Gen Pract; 2022 Nov; 51(11):845-848. PubMed ID: 36310001 [TBL] [Abstract][Full Text] [Related]
16. The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events. Elias E; Targownik LE Drugs; 2019 May; 79(7):715-731. PubMed ID: 30972661 [TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitors: What the Internist Needs to Know. Spechler SJ Med Clin North Am; 2019 Jan; 103(1):1-14. PubMed ID: 30466666 [TBL] [Abstract][Full Text] [Related]
18. To wean or not to wean: proton pump inhibitor management after anti-reflux surgery amongst foregut experts. Pflüger MJ; Coker AM; Zosa BM; Adrales GL; Parker BC Surg Endosc; 2024 Jul; 38(7):3992-3998. PubMed ID: 38844731 [TBL] [Abstract][Full Text] [Related]
19. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer. Sharma M; Holmes HM; Mehta HB; Chen H; Aparasu RR; Shih YT; Giordano SH; Johnson ML Cancer; 2019 Apr; 125(7):1155-1162. PubMed ID: 30605231 [TBL] [Abstract][Full Text] [Related]